OneDigital Investment Advisors’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$408K Buy
10,464
+1,871
+22% +$60.4K ﹤0.01% 1131
2026
Q1
$280K Sell
8,593
-2,019
-19% -$64.9K ﹤0.01% 1222
2025
Q4
$373K Buy
10,612
+1,059
+11% +$37.5K ﹤0.01% 1096
2025
Q3
$251K Buy
+9,553
New +$285K ﹤0.01% 1295
2025
Q1
– Sell
-5,189
Closed -$209K – 1498
2024
Q4
$209K Buy
5,189
+1,929
+59% +$110K ﹤0.01% 1317
2024
Q3
$206K Buy
+3,260
New +$191K ﹤0.01% 1356
2019
Q3
– Sell
-542
Closed -$4K – 1138
2019
Q2
$4K Hold
542
– – ﹤0.01% 1086
2019
Q1
$5K Hold
542
– – ﹤0.01% 994
2018
Q4
$4K Buy
+542
New +$6.48K ﹤0.01% 985

Other funds holding VKTX

OneDigital Investment Advisors's VKTX Position: Q2 2026 in Review

OneDigital Investment Advisors increased its Viking Therapeutics (VKTX) stake by 22% in Q2 2026, buying an estimated $60.4K and bringing the position to 10,464 shares worth $408K. The position accounts for ﹤0.01% of the portfolio, ranked #1131.

OneDigital Investment Advisors first reported a position in VKTX in Q4 2018 and has held it in 9 quarters since. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • OneDigital Investment Advisors held 10,464 shares of Viking Therapeutics worth $408K as of Q2 2026.
  • OneDigital Investment Advisors bought 1,871 Viking Therapeutics shares in Q2 2026, an estimated $60.4K.
  • Viking Therapeutics made up ﹤0.01% of OneDigital Investment Advisors's portfolio in Q2 2026, its #1131 holding.
  • OneDigital Investment Advisors first reported a position in Viking Therapeutics in Q4 2018 and has held it in 9 quarters since.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on OneDigital Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.